GSA Capital Partners’s NEVRO CORP. NVRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-31,209
Closed -$793K 1996
2023
Q2
$793K Buy
31,209
+17,732
+132% +$512K 0.08% 444
2023
Q1
$487K Sell
13,477
-19,326
-59% -$679K 0.05% 737
2022
Q4
$1.3M Buy
+32,803
New +$1.36M 0.16% 101
2022
Q3
Sell
-6,199
Closed -$272K 1934
2022
Q2
$272K Buy
+6,199
New +$341K 0.04% 884
2021
Q1
Sell
-2,426
Closed -$420K 1562
2020
Q4
$420K Buy
+2,426
New +$393K 0.07% 536
2020
Q1
Sell
-2,684
Closed -$315K 1651
2019
Q4
$315K Buy
+2,684
New +$266K 0.04% 987

Other funds holding NVRO

GSA Capital Partners's NVRO Position: Q3 2023 in Review

GSA Capital Partners sold out of NEVRO CORP. (NVRO) in Q3 2023, closing a stake of 31,209 shares — an estimated $793K sold.

GSA Capital Partners first reported a position in NVRO in Q4 2019 and held it in 6 quarters. The position peaked at $1.3M in Q4 2022. 136 funds tracked by Wall St. Rank hold NVRO as of Q3 2023.

  • GSA Capital Partners reported no remaining NEVRO CORP. position as of Q3 2023 after selling out during the quarter.
  • GSA Capital Partners sold 31,209 NEVRO CORP. shares in Q3 2023, an estimated $793K.
  • GSA Capital Partners first reported a position in NEVRO CORP. in Q4 2019 and held it in 6 quarters.
  • GSA Capital Partners's NEVRO CORP. position peaked at $1.3M in Q4 2022.
  • 136 funds tracked by Wall St. Rank held NEVRO CORP. as of Q3 2023.

Based on GSA Capital Partners's 13F filing for Q3 2023, filed 15 Nov 2023.